Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio SciencesPR Newswire • 19 days ago
Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences PR Newswire...
Share to Feed
This indicator may be signaling DNLI's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
It has been about a month since the last earnings report for Sarepta Therapeutics (SRPT). Shares have added about 1.2% in that time frame, underperforming the S&P 500.Will the recent positive trend...
A month has gone by since the last earnings report for Denali Therapeutics Inc. (DNLI). Shares have added about 2.8% in that time frame, underperforming the S&P 500.Will the recent positive trend...
Denali Therapeutics files to sell 29.29M shares of common stock for holders...
This indicator may be signaling DNLI's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative...
This is a Bearish indicator signaling DNLI's price could decline from here. Traders may explore shorting the stock or put options...
This indicator may be signaling DNLI's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Northern Trust Corp grew its stake in shares of Denali Therapeutics Inc. (NASDAQ:DNLI Free Report) by 2.5% during the third quarter, according to the company in its most recent 13F filing...